Trial Profile
Phase IV; Different Extend Treatment Duration (6 Months vs 12 Months After Chemotherapy) to Prevent HBV Relapse With Tenofovir for Prophylaxis in Patients With Malignant Tumor Combined With HBV Carrier Receiving Chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Nov 2023
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 30 Jan 2020 Status changed from recruiting to completed.
- 07 May 2014 New trial record